Atlas Trials

Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)

Clinical trial NCT04891055 · UNKNOWN

Trial details

NCT number
NCT04891055
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
UNKNOWN
Study type
OBSERVATIONAL
Metastatic Renal Cell Carcinoma
Start date
2018-11-29
Primary completion
2021-11-29
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.